Utah Medical Products, Inc. (UTMD)

Utah Medical Products, Inc. (UTMD) is a healthcare company (medical instruments & supplies) based in the United States. The share price is $72.15, down 0.29% on the day, which values the company at $205.59M. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$72.15−0.29% today
Market value
$205.59M
P/E ratio
21.6×last 12 months
Dividend yield
1.71%
Funk Score
57/100
Against its own history
About its usual priceusual price $71.62
200-week average
$70.852% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Utah Medical Products, Inc. in more detail

UTMD trades at 21.6× its last twelve months' earnings, 5.9× sales. Measured against its own history, the price is 1% above what its usual multiples would imply ($71.62) — about its usual price. It sits 2% above its 200-week average of $70.85.

Over the last five fiscal years Utah Medical Products, Inc. has compounded revenue -1.8% a year, earnings per share 3.4% a year, free cash flow -5.8% a year. Its Funk Score is 57 out of 100 (financial strength 9.2, profitability 8.0, growth 1.4, value 4.4, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling. Worth checking: Gross margin is shrinking; Revenue is shrinking.

1 of the superinvestors tracked here hold UTMD, including Charles Brandes (founder) (0.3% of the portfolio).

Superinvestors holding UTMD

1 of the investors tracked here report a position in their latest 13F filing.

Utah Medical Products, Inc. (UTMD): questions and answers

What is UTMD's P/E ratio?

Utah Medical Products, Inc. trades at 21.6× its last twelve months' earnings. At its fiscal year-ends over the past 17 years the P/E ranged from 13.2× to 35.7×, with a median of 18.6×.

What is UTMD's PEG ratio?

Utah Medical Products, Inc.'s PEG ratio is 4.25 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Utah Medical Products, Inc.'s market cap?

Utah Medical Products, Inc. is valued at $205.59M at a share price of $72.15.

Is UTMD overvalued or undervalued?

Against its own history, UTMD is about its usual price: the price is 1% above the $71.62 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is UTMD above its 200-week moving average?

Yes. UTMD is 1.8% above its 200-week average of $70.85. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Utah Medical Products, Inc. growing?

Over the last five fiscal years Utah Medical Products, Inc.'s revenue grew -1.8% a year and its earnings per share 3.4% a year; over ten years revenue grew -0.4% a year.

Cite this page

Funkfolio, “Utah Medical Products, Inc. (UTMD) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/UTMD

Underlying data: Yahoo Finance; company filings with the SEC.